mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
-0.039 |
0.8 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |